CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
-20.32%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.3B
AUM Growth
+$1.3B
Cap. Flow
+$104M
Cap. Flow %
7.98%
Top 10 Hldgs %
48.93%
Holding
86
New
8
Increased
9
Reduced
24
Closed
9

Top Buys

1
GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$62M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
$28.9M
3
APLS icon
Apellis Pharmaceuticals
APLS
$25.4M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$19M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$18.1M

Top Sells

1
BEAM icon
Beam Therapeutics
BEAM
$23.5M
2
ACRS icon
Aclaris Therapeutics
ACRS
$13.1M
3
RVMD icon
Revolution Medicines
RVMD
$11.1M
4
CYTK icon
Cytokinetics
CYTK
$11M
5
ZYME icon
Zymeworks
ZYME
$9.83M

Sector Composition

1 Healthcare 98.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CYTK icon
26
Cytokinetics
CYTK
$5.98B
$14.7M 1.13%
400,000
-300,000
-43% -$11M
BMEA icon
27
Biomea Fusion
BMEA
$114M
$14.1M 1.09%
3,170,872
– –
RCKT icon
28
Rocket Pharmaceuticals
RCKT
$358M
$13.8M 1.06%
868,550
– –
PHVS icon
29
Pharvaris
PHVS
$1.41B
$12.4M 0.95%
684,888
-4,843
-0.7% -$87.8K
LBPH
30
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$12.1M 0.93%
2,273,221
– –
ALXO icon
31
ALX Oncology
ALXO
$54.6M
$12M 0.92%
712,079
-50,000
-7% -$845K
RAIN
32
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$11.8M 0.91%
2,326,660
– –
TRML icon
33
Tourmaline Bio
TRML
$645M
$11.6M 0.89%
1,174,723
-7,822
-0.7% -$77K
AVIR icon
34
Atea Pharmaceuticals
AVIR
$275M
$11.2M 0.86%
1,547,181
-132,261
-8% -$955K
GHRS icon
35
GH Research
GHRS
$870M
$11.1M 0.85%
608,123
– –
IGMS
36
DELISTED
IGM Biosciences
IGMS
$10.8M 0.83%
402,200
-97,800
-20% -$2.61M
VTYX icon
37
Ventyx Biosciences
VTYX
$184M
$10.7M 0.82%
785,303
– –
HZNP
38
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.5M 0.81%
+100,000
New +$10.5M
AMAM
39
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
$10.2M 0.79%
2,486,386
– –
BCAB icon
40
BioAtla
BCAB
$28.7M
$10.2M 0.78%
2,038,215
+357,100
+21% +$1.79M
VECT
41
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$9.79M 0.75%
2,078,485
-138,278
-6% -$651K
BHVN
42
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$9.49M 0.73%
+80,000
New +$9.49M
ITCI
43
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$9.18M 0.7%
+150,000
New +$9.18M
OLMA icon
44
Olema Pharmaceuticals
OLMA
$432M
$8.87M 0.68%
2,082,000
-87,871
-4% -$374K
TYRA icon
45
Tyra Biosciences
TYRA
$657M
$8.11M 0.62%
757,432
-82,500
-10% -$883K
PRAX icon
46
Praxis Precision Medicines
PRAX
$980M
$7.68M 0.59%
752,406
– –
ASND icon
47
Ascendis Pharma
ASND
$12.1B
$5.87M 0.45%
50,000
– –
AKRO icon
48
Akero Therapeutics
AKRO
$3.65B
$5.73M 0.44%
403,787
– –
KROS icon
49
Keros Therapeutics
KROS
$640M
$5.44M 0.42%
100,000
-50,000
-33% -$2.72M
BEAM icon
50
Beam Therapeutics
BEAM
$1.9B
$5.16M 0.4%
90,045
-409,955
-82% -$23.5M
1
2
3 4